Hong Kong Journal of Nephrology
Volume 10, Issue 1 , Pages 1-6, April 2008

Science and Care in Nephrology: Journey from Prevention to Peritoneal Dialysis

  • Philip K.T. Li

      Affiliations

    • Corresponding Author InformationCorrespondence to: Professor Philip K.T. Li, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR. Fax: (+852) 2637-5396;

Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR.

Article Outline

In the management of chronic kidney disease (CKD), there is a large number of patients at risk for renal failure who require renoprotection programs and, at the same time, a much smaller number of patients with end-stage kidney disease who require very costly renal replacement programs. Among the exciting innovations with regard to science and care in nephrology, the areas of prevention and cost-effective quality care of CKD patients using peritoneal dialysis (PD) has seen many new developments, exemplified by work done in the Prince of Wales Hospital in Hong Kong. However, while successes in PD have been achieved, there remain many areas that require further improvement, such as technique failure, prevention and treatment of peritoneal infections, peritoneal access, adequacy of solute removal, peritoneal physiology and changes with long-term PD, patient fatigue, cardiovascular mortality, severe malnutrition, preservation of residual renal function, and metabolic and inflammatory problems. The center in the Prince of Wales Hospital has focused on clinical and basic science research to address these areas, with the aim of making PD a more cost-effective mode of renal replacement therapy with excellent quality. The following areas are highlighted in this review: prevention and treatment of peritonitis, the use of angiotensin-converting enzyme inhibitors in preserving residual renal function, oral bicarbonate in improving acidosis and nutritional status, thiazolidinediones in reducing insulin resistance and inflammation, and the use of biocompatible dialysis solutions in improving peritoneal membrane permeability and reducing inflammation.

Key words:  chronic kidney disease , peritoneal dialysis , prevention

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Li PKT , Dirks J , Weening JJ . A time to act for prevention . Kidney Int . 2005;(94):s1
  2. U.S. Renal Data System  . USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States . Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007;
  3. Hong Kong Renal Registry. Hong Kong Renal Registry data, 2005.
  4. Li PKT, Weening JJ, Dirks J, Lui SL, Szeto CC, Tang S, et al  A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease . Kidney Int . 2005;(94):s2–s7
  5. Li PKT, Kwan BC, Leung CB, Kwan TH, Wong KM, Lui SL, et al  Prevalence of silent kidney disease in Hong Kong: the Screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program . Kidney Int . 2005;(94):s36–s40
  6. Li PKT , Leung CB , Chow KM , Cheng YL , Fung SK , Mak SK , et al.   Hong Kong study using Valsartan in IgA Nephropathy (HKVIN)—a double-blind randomized placebo-controlled study . Am J Kidney Dis . 2006;47:751–760
  7. Li PKT . Is angiotensin-converting-enzyme inhibition renoprotective in young patients with IgA nephropathy? . Nat Clin Pract Nephrol . 2007;3:594–595
  8. Szeto CC , Chow KM , Woo KS , Chook P , Kwan BC , Leung CB , et al.   Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease . J Am Soc Nephrol . 2007;18:1966–1972
  9. Li PKT , Ho KKL , Szeto CC , Yu LM , Lai FM . Prognostic indicators of IgA nephropathy in the Chinese—clinical and pathological perspectives . Nephrol Dial Transplant . 2002;17:64–69
  10. Li PKT , Lui SL , Leung CB , Yu AW , Lee E , Just PM , et al.   Increase utilization of peritoneal dialysis as a means to cope with mounting demand for renal replacement therapy—perspectives from Asian countries . Perit Dial Int . 2007;27:S59–S61
  11. Li PKT , Chung KY , Chow KM . CAPD is better than APD as first line treatment in renal replacement therapy . Perit Dial Int . 2007;27:S153–S157
  12. Li PKT , Szeto CC . Success of the peritoneal dialysis programme in Hong Kong . Nephrol Dial Transplant . 2008 Feb 26; [Epub].
  13. Li PKT , Chow KM , Szeto CC . Is there a survival advantage in Asian peritoneal dialysis patients? . Int J Artif Organs . 2003;26:363–372
  14. Li PKT , Law MC , Chow KM , Leung CB , Kwan BC , Chung KY , et al.   Good patient and technique survival in elderly patients on continuous ambulatory peritoneal dialysis . Perit Dial Int . 2007;27:S196–S201
  15. Li PKT , Law MC , Chow KM , Chan WK , Szeto CC , Cheng YL , et al.   Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis-a prospective randomized controlled multi-center study . Am J Kidney Dis . 2002;40:373–380
  16. Li PKT , Leung CB , Szeto CC . Peritonitis in peritoneal dialysis patients . In:  Nissenson AR ,  Fine R editor. Dialysis Therapy . 4th edition. Amsterdam: Elsevier; 2007;p. 396–413 Chapter 32
  17. Li PKT , Chow KM . The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients . Perit Dial Int . 2005;25:S80–S83
  18. Li PKT , Cheng YL . Therapeutic options for preservation of residual renal function in patients on peritoneal dialysis . Perit Dial Int . 2007;27(S2):S158–S163
  19. Li PKT , Chow KM , Wong TY , Leung CB , Szeto CC . Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study . Ann Intern Med . 2003;139:105–112
  20. Li PKT , Chan TH , So WY , Wang AY , Leung CB , Lai KN . Comparisons of Y-set disconnect system (Ultraset) versus conventional spike system in uremic patients on CAPD: outcome and cost analysis . Perit Dial Int . 1996;16(Suppl 1):S368–S370
  21. Li PKT , Szeto CC , Law MC , Chau KF , Fung KS , Leung CB , et al.   Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis-a prospective randomized controlled multi-center study . Am J Kidney Dis . 1999;33:535–540
  22. Chow KM , Szeto CC , Cheung KK , Leung CB , Wong SS , Law MC , et al.   Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis . Clin J Am Soc Nephrol . 2006;1:768–773
  23. Leung CB , Szeto CC , Chow KM , Kwan BC , Wang AY , Lui SF , et al.   Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis-a randomized controlled trial . Perit Dial Int . 2004;24:440–446
  24. Szeto CC , Wong TY , Chow KM , Leung CB , Li PKT . Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients-a randomized placebo-control trial . J Am Soc Nephrol . 2003;14:2119–2126
  25. Wong TY , Szeto CC , Chow KM , Leung CB , Lam CW , Li PKT . Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis . Am J Kidney Dis . 2005;46:713–719
  26. Szeto CC , Chow KM , Lam CW , Leung CB , Kwan BC , Chung KY , et al.   Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation-products—a one-year randomized control trial . Nephrol Dial Transplant . 2007;22:552–559

PII: S1561-5413(08)60012-5

doi:10.1016/S1561-5413(08)60012-5

Hong Kong Journal of Nephrology
Volume 10, Issue 1 , Pages 1-6, April 2008

Article Tools